The American Botanical Drug Association (ABDA) is a 501(c)(3) tax-exempt nonprofit organization. ABDA’s mission is to champion the advancement of natural herbal formulations into prescription medicines as US FDA-approved Botanical Drugs:
Increase public awareness of botanical drugs
Increase options in the healthcare system
Facilitate the formation of healthcare policies
Serve as a platform for dialogue and collaboration between government agencies, private entities, and academics, by means of conferences and meetings
Promote collaboration between the pharmaceutical and botanical industries
Establish international standards for botanical drugs and their medical usage
Using currently available modern scientific data, and existing evidence of efficacy in markets outsides the US, ABDA has developed partnerships with botanical research institutes around the world for the purpose of botanical drug development. ABDA and Research Institutes work through a series of steps to bring herbal medicines into the US prescription market:
identify promising herbal formulas in areas of oncology, diabetics, and infectious diseases including COVID
produce in vitro, in vivo, PK, PD, and HPLC data
conduct US FDA regulatory IND applications
Our vision is to evolve safe and effective botanical products into prescription botanical drugs through the FDA’s botanical drug development pathway.